VivoSim Labs, Inc. (VIVS)

NASDAQ

$0,26

$-0,01

(-2,60%)

Pre-Market

VivoSim Labs, Inc. (VIVS) Live Price Chart

Last updated: ⁦2026-09-17 11:54:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

VivoSim Labs, Inc. (VIVS) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0,26, with a market capitalization of $3,65M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,25 to $4,20. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$3,65M
Open	$0,27
Day's High	$5,30
Day's Low	$0,25
Previous Close	$0,26
Volume	109,88K
Average Volume	5,80M
P/E Ratio	--
52-Week High	$4,20
52-Week Low	$0,25
Dividend Yield	--
Earnings Date	--

VivoSim Labs, Inc. (VIVS) Pre-Market Stock Price

VivoSim Labs, Inc. (VIVS) is trading at $0,26 in pre-market trading as of 2026-09-17 11:48:00, down 0,04% ($0,00) from the previous close of $0,26

Pre-market trading shows how investors are pricing VIVS before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.

VivoSim Labs, Inc. (VIVS) 7-Day Stock Price Change

Over the past seven days, VivoSim Labs, Inc. (VIVS) moved from $0,28 to $0,26, representing a decline of 6,99% ($0,02).

The stock traded between $0,25 and $0,30 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1,43 million shares, up versus the previous seven-day period, indicating higher trading activity.

VIVS 52-Week Price Position

Position in Range: 0,4%

52W Low$0,25

52W High$4,20

VIVS is currently trading at $0,26, placing it 0,4% of the way from its 52-week low of $0,25 to its 52-week high of $4,20. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is VivoSim Labs, Inc. (VIVS)?

VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.

VivoSim Labs, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	11
Exchange	NASDAQ
Company Website	https://www.organovo.com

How to Buy VivoSim Labs, Inc. (VIVS) Stock on MEXC

Eligible investors can buy real shares of VivoSim Labs, Inc. (VIVS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for VIVS and Place Your Order

Open the RealStocks trading page and search for VIVS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is VivoSim Labs, Inc. (VIVS) stock price today?

VivoSim Labs, Inc. (VIVS) is currently trading at $ 0,26, down 0,04% ($0,00) from the previous close of $ 0,26. Intraday prices update in real time during regular trading hours.

2.Is VIVS stock going up or down today?

As of 2026-09-17 11:48:00, VIVS is trading at $ 0,26, down 0,04% ($0,00) from its previous close of $ 0,26. The stock has traded between $ 0,25 and $ 5,30 during today’s regular session. Past price movements do not guarantee future results.

3.What is VIVS pre-market price?

As of 2026-09-17 11:48:00, VIVS is trading at $ 0,26 in pre-market trading, down 0,04% ($0,00) from the previous close of $ 0,26. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is VIVS after-hours price?

As of 2026-09-17 11:48:00, VIVS is trading at $ 0,27 in after-hours trading, up 2,25% ($0,01) from the regular-session close of $ 0,26. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is VIVS stock trading now?

VIVS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does VIVS sit relative to its 52-week high and low?

Over the past 52 weeks, VIVS has traded between a low of $ 0,25 and a high of $ 4,20. At $ 0,26, the stock is positioned 0,4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is VivoSim Labs, Inc. in?

VivoSim Labs, Inc. (VIVS) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is VivoSim Labs, Inc.'s market capitalization and where is it listed?

VivoSim Labs, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 3,65M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is VIVS valued in terms of P/E ratio and EPS?

VIVS trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0,92. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does VivoSim Labs, Inc. pay a dividend?

VivoSim Labs, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.